MeSH tree: C17.300
The Abigail Wexner Research Institute at Nationwide Children's Hospital celebrated the Food and Drug Administration's (FDA) approval of FAYUVI for Sanfilippo syndrome type A, following years of research in its Jerry R. Mendell ...
Sep 23, 2026
0
13
Some genetic disorders have a clear connection between the affected gene product and the suite of symptoms produced. But genes do not work in isolation, and many other conditions can be bafflingly complex, as when an affected ...
Sep 21, 2026
0
23
Early, consistently managed treatment can have a decisive impact on the course of rheumatoid arthritis and prevent permanent joint damage. An international review led by Josef S. Smolen of the Medical University of Vienna ...
Sep 11, 2026
0
13
Why do genetic variants that increase the risk of autoimmune disease remain so common in the population?
Sep 11, 2026
0
9
Investigators at Cedars-Sinai Health Sciences University used an experimental drug to reverse the effects of systemic sclerosis, a serious autoimmune disease. The study, conducted in a laboratory, was published in JCI Insight.
Sep 8, 2026
0
18
Autoimmune diseases arise when the immune system mistakenly attacks the body's own tissues. Researchers have long known that these diseases tend to run in families, but the genetic relationships between different autoimmune ...
Sep 4, 2026
0
384
The U.S. Food and Drug Administration has approved Lisraya (brepocitinib) tablets as the first oral treatment for dermatomyositis in adults.
Sep 1, 2026
0
5
Immunotherapies such as CAR T-cell therapy are used primarily to treat cancer. In the future, these patient-specific therapies, manufactured from patients' own immune cells, could also help cure autoimmune diseases. Six patients ...
Aug 27, 2026
0
1008
Keloids are abnormal fibroproliferative scars that form when overactive fibroblasts produce excessive collagen after skin injury. Unlike ordinary scars, they can extend beyond the original wound and cause itching, pain and ...
Aug 27, 2026
0
6
An Australian research collaboration has identified several existing TGA-approved medicines that could help slow brain damage in children with a rare form of dementia—offering hope for faster treatment options.
Aug 20, 2026
0
11
